CROS NT

New hires at CROS NT

CROS NT Activity on LinkedIn

  • CROS NT
    CROS NT $1.3 billion to bring a new drug to market, the biggest expense is failure. How to make clinical trials more efficient and cost-effective....?
    1 day ago
  • CROS NT
    CROS NT
    2 days ago
  • CROS NT
    CROS NT CROS NT has registered and booked for the DIA EuroMeeting in Copenhagen, Denmark. We will be at Booths #725 and 727 this year. Stop by for your chance to win an iPod Touch.
    8 days ago
  • CROS NT
    CROS NT Early Bird Registration has opened for Italian ePharma Day! Register now and save. The topic of this year's event is "Traceability in Clinical Trials: from Trial Design to Submission".
    9 days ago
  • CROS NT
    CROS NT
    10 days ago
  • CROS NT
    CROS NT
    16 days ago
  • CROS NT
    CROS NT
    18 days ago
  • CROS NT
    CROS NT There have been some changes to the ePharma Day Series 2012. There is a new title and focus on Traceability in Clinical Trials. Also, the German ePharma Day has been moved to Frankfurt. Check out the PR for more!
    20 days ago
  • CROS NT
    CROS NT The 24th Annual DIA EuroMeeting is fast approaching. CROS NT will be exhibiting at Booths #725 and 727. Be sure to come by and see us!
    21 days ago
  • CROS NT
    CROS NT What are your thoughts on pharma drug development costs? What is pharma doing to manage these costs?
    21 days ago

See all activity »

Type
Privately Held
Company Size
51-200 employees
Website
http://www.crosnt.com
Industry
Pharmaceuticals
Founded
1992

Headquarters

Via Germania 2 Verona, VERONA 37136 Italy
CROS NT Headquarters

This LinkedIn Company Profile was created by LinkedIn and is about CROS NT. This page is not endorsed by or affiliated with CROS NT. For questions regarding LinkedIn Company Profiles contact us.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions